MarketPeel
Insider Trading Intelligence
Pricing
…
LB

Liisa Ann Bayko

KLRS
CHIEF FINANCIAL OFFICER · KALARIS THERAPEUTICS, INC. · CIK 0002145720
FILING MIX · LIFETIME100%/0%
BUYS
1
SELLS
0
TOTAL VALUE
$0
COMPANIES
1
ACTIVE SINCE
Jul 2026
HOLDINGS NOW
220,000
AVG SELL PX
—
TRADE KIND
SHOWING 1 / 1
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
No backtest data available for Liisa Ann Bayko. Backtests are computed for purchase (P) and sale (S) transactions with resolvable price history.
Holdings over time
Not enough transaction history to chart holdings.
Trading cadence · quarterly flow
BUY ● SELL ●
2026
FLOW · 1 buys / 0 sellsCOVERAGE · 1 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
KLRS
KALARIS THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
220,000——220,000Jul 20, 2026Jul 20, 2026 ↗View →
Other insiders · KLRS
Loading peer insiders…
About this filer
CIK 0002145720
ROLE
Chief Financial Officer
PRIMARY
KLRS
COMPANIES
1
ACTIVE SINCE
Jul 2026
MARKETPEEL · /INSIDER/0002145720DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback